Jonathan W. Goldman, M.D. is an Associate Professor of Medicine at UCLA in the Hematology/Oncology Division. He is the UCLA Director of Clinical Trials in Thoracic Oncology and the Associate Director of Early Drug Development. His research focuses on the development of new treatments for thoracic and other solid cancers. Most recently he has been investigating novel antibody-drug conjugates, small cell lung cancer therapies, and combination targeted therapies.
Medical Board Certifications
Areas of Focus
Lung cancer, targeted therapy, immune therapy.